Precal Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

Precal General Information

Description

Developer of an automatic input entry designed to eliminate prescription entry tasks. The company's platform transmits and scans the prescription image online remotely and inputs the data like patient information, insurance information, chemical, and drug composition automatically, enabling pharmacies to reduce the need for workers to manually fill in the prescription data.

Contact Information

Website
about.precal.jp
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 1-10-9 Jingumae
  • Onden Flat Room 302, Shibuya-ku
  • Tokyo, 150-0001
  • Japan
Primary Industry
Other Healthcare Technology Systems
Other Industries
Medical Records Systems
Parent Company
Corporate Office
  • 1-10-9 Jingumae
  • Onden Flat Room 302, Shibuya-ku
  • Tokyo, 150-0001
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Precal Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 11-Sep-2025 Completed Generating Revenue
6. Later Stage VC 04-Dec-2024 Completed Generating Revenue
5. Later Stage VC (Series B) 15-Jan-2024 Completed Generating Revenue
4. Early Stage VC 11-May-2022 Completed Generating Revenue
3. Seed Round 25-Mar-2021 Completed Generating Revenue
2. Accelerator/Incubator 27-Feb-2020 Completed Startup
1. Accelerator/Incubator 09-Oct-2019 Completed Startup
To view Precal’s complete valuation and funding history, request access »

Precal Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class C Preferred Shares
Class B2 Preferred
Class B Preferred
Class A2 Preferred 866 $150.74 $150.74 1x $150.74 3.49%
Class A Preferred 2,512 $259.89 $259.89 1x $259.89 10.13%
To view Precal’s complete cap table history, request access »

Precal Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Precal Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
AI. Accelerator Accelerator/Incubator Minority
Angel Bridge Angel Group Minority
CyberAgent Capital Corporate Venture Capital Minority
DBJ Capital Corporate Venture Capital Minority
DG Ventures Corporate Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

Precal FAQs

  • When was Precal founded?

    Precal was founded in 2019.

  • Where is Precal headquartered?

    Precal is headquartered in Tokyo, Japan.

  • What is the size of Precal?

    Precal has 20 total employees.

  • What industry is Precal in?

    Precal’s primary industry is Other Healthcare Technology Systems.

  • Is Precal a private or public company?

    Precal is a Private company.

  • What is Precal’s current revenue?

    The current revenue for Precal is .

  • How much funding has Precal raised over time?

    Precal has raised $3.87M.

  • Who are Precal’s investors?

    AI. Accelerator, Angel Bridge, CyberAgent Capital, DBJ Capital, and DG Ventures are 5 of 13 investors who have invested in Precal.

  • When was Precal acquired?

    Precal was acquired on 11-Sep-2025.

  • Who acquired Precal?

    Precal was acquired by EM Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process